바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
사전등록 바로가기
 

logo

메뉴
search

ISSN : 0376-4672

논문 상세

이전
논문 투고

61권 8호

전신질환을 동반한 장애인 환자에서의 임플란트 수술 시 고려사항

Considerations for implant surgery in disabled patients with medical history

곽은정 (서울대학교치과병원 중앙장애인구강진료센터)
대한치과의사협회지 / The Journal of the Korean Dental Association, (P)0376-4672; (E)2713-7961
2023, v.61 no.8, pp.537-544
https://doi.org/10.22974/jkda.2023.61.8.004
곽은정. (2023). 전신질환을 동반한 장애인 환자에서의 임플란트 수술 시 고려사항. 대한치과의사협회지, 61(8), 537-544, https://doi.org/10.22974/jkda.2023.61.8.004

Abstract

As the accessibility of dental treatment for the disabled has improved and the need for oral care has emerged, implant restoration has been adopted as one of the treatment methods for restoring the missing teeth in these patients. However, considering the characteristics of disabled patients and the level of cooperation should be considered. It is necessary to check for medication and consider any systemic diseases that may be affected by invasive surgery. In particular, patients taking antiplatelet, anticoagulant, or osteoporosis drugs, or in a state of organ transplantation, invasive implant surgery should be more cautious. In this article, the considerations for various medical history and characteristics of several types of disability would be discussed.

keywords
Implant surgery, disabled patient, bleeding tendency, organ transplantation

참고문헌

1.

1. Weltman NJ, Al-Attar Y, Cheung J, Duncan DP, Katchky A, Azarpazhooh A, Abrahamyan L. MANAGEMENT OF DENTAL EXTRACTIONS IN PATIENTS TAKING WARFARIN AS ANTICOAGULANT TREATMENT: A SYSTEMATIC REVIEW. J Can Dent Assoc. 2015;81:f20.

2.

2. Manor Y, Peleg O, Mijiritsky E, Manor A, Reiter S. A retrospective analysis of dental implantation under anticoagulant treatment. Clin Oral Investig. 2021 Mar;25(3):1001-1009.

3.

3. Verdecchia P, Angeli F, Aita A, Bartolini C, Reboldi G. Why switch from warfarin to NOACs? Intern Emerg Med 2016;11(3):289-93.

4.

4. Samama MM, Guinet C. Laboratory assessment of new anticoagulants. Clin Chem Lab Med 2011;49(5):761-72.

5.

5. Curto A, Albaladejo A. Implications of apixaban for dental treatments. J Clin Exp Dent 2016;8(5):e611-e14.

6.

6. Kwak EJ, Nam S, Park KM, et al. Bleeding related to dental treatment in patients taking novel oral anticoagulants (NOACs): a retrospective study. Clin Oral Investig 2019;23(1):477-84.

7.

7. Stavropoulos A, Bertl K, Pietschmann P, et al. The effect of antiresorptive drugs on implant therapy: Systematic review and meta-analysis. Clin Oral Implants Res 2018;29 Suppl 18:54-92.

8.

8. Ruggiero SL, Dodson TB, Aghaloo T, et al. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg 2022;80(5):920-43.

9.

9. Ito HO. Infective endocarditis and dental procedures: evidence, pathogenesis, and prevention. J Med Invest 2006;53(3-4):189-98.

10.

10. Holland TL, Baddour LM, Bayer AS, et al. Infective endocarditis. Nat Rev Dis Primers 2016;2:16059.

11.

11. Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. Circulation 2021;143(20):e963-e78.

12.

12. Lockhart PB, Bolger A, Baddour LM. The 2021 American Heart Association Statement on prevention of infective endocarditis:What's new? J Am Dent Assoc 2021;152(11):880-82.

13.

13. Weinberg MA, Segelnick SL, Kay LB, Nair V. Medical and dental standardization for solid organ transplant recipients. N Y State Dent J 2013;79(6):35-40.

14.

14. Guggenheimer J, Eghtesad B, Stock DJ. Dental management of the (solid) organ transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95(4):383-9.

15.

15. Kwak EJ, Kim DJ, Choi Y, Joo DJ, Park W. Importance of oral health and dental treatment in organ transplant recipients. Int Dent J 2020;70(6):477-81.

16.

16. Eyler RF, Shvets K. Clinical Pharmacology of Antibiotics. Clin J Am Soc Nephrol 2019;14(7):1080-90.

17.

17. Aloy B, Launay-Vacher V, Bleibtreu A, et al. Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice. Med Mal Infect 2020;50(4):323-31.

18.

18. Song JY. Implant complications in bruxism patients. J Korean Assoc Oral Maxillofac Surg. 2021 Apr 30;47(2):149-150.

19.

19. Lobbezoo F, Brouwers JE, Cune MS, Naeije M. Dental implants in patients with bruxing habits. J Oral Rehabil. 2006Feb;33(2):152-9.

20.

20. Misch CE. The effect of bruxism on treatment planning for dental implants. Dent Today. 2002 Sep;21(9):76-81. PMID:12271847.

21.

21. Merheb J, Vercruyssen M, Coucke W, Quirynen M. Relationship of implant stability and bone density derived from computerized tomography images. Clin Implant Dent Relat Res 2018;20(1):50-57.

22.

22. Andreotti AM, Goiato MC, Nobrega AS, et al. Relationship Between Implant Stability Measurements Obtained by Two Different Devices: A Systematic Review. J Periodontol 2017;88(3):281-88.

23.

23. Chen P, Nikoyan L. Guided Implant Surgery: A Technique Whose Time Has Come. Dent Clin North Am 2021;65(1):67-80.

24.

24. D'Haese J, Ackhurst J, Wismeijer D, De Bruyn H, Tahmaseb A. Current state of the art of computer-guided implant surgery. Periodontol 2000 2017;73(1):121-33.

logo

논문 투고
OA 정책